The aldosterone-renin screening market is forecasted to grow from USD 574.8 million in 2025 to USD 1,109.7 million by 2035, at a CAGR of 6.8% during the forecast period. The aldosterone-renin screening market plays a vital role in the global diagnostic landscape, especially with the increasing prevalence of hypertension and related endocrine disorders. This market …